Finally there is life in the penny stock of Generex Biotechnology Corp. (OTC: GNBT) after the Breast Cancer Vaccine makers made three seperate announcements. GNBT stock currently trading up 17.84% at 0.109 on more than 5x the 10 day aveage volume after the Company announced an End-of-Phase II meeting has been scheduled with the FDA in respect of the Phase II clinical ...
7
JUN
JUN
0
Share
